49.8 F
New York
Monday, November 23, 2020

Vir Biotechnology Inc. (NASDAQ:VIR) Recent Earnings Shows Major Concern

Must read

When Will New Gold Inc. (NGD) Slow Down

New Gold Inc. (NGD) shares are trading at higher $1.82 and the avg recommendation for the stock is Moderate Buy. To add more color...

The Forecast Just Changed on Bed Bath & Beyond Inc. (NASDAQ:BBBY)

Bed Bath & Beyond Inc. (BBBY) shares are trading at lower $20.24 and the avg recommendation for the stock is Moderate Buy, while the...

Will Hyliion Holdings Corp. (HYLN) Find a Support Level Soon?

Hyliion Holdings Corp. (HYLN) shares are trading at higher $25.10 and the avg recommendation for the stock is Hold, while the current analyst price...

The Gap Inc. (GPS)’s Stock is Jumping, Here is Why

The Gap Inc. (GPS) shares are trading at lower $24.37 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Vir Biotechnology Inc. (VIR) shares are trading at lower $50.43 and the avg recommendation for the stock is Hold. while the current analyst price target stands at $39.50.

To add more color to this target, the company’s high over the last year is $75.00 and the low is $11.65. Over the last 52 weeks, VIR is down -32.76% while the S&P 500 is down -0.42%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, VIR reported a profit of $96.04 million. Vir Biotechnology Inc. also saw revenues increase to $66.99 million. In addition, VIR has free cash flow of -$61.69 million as of 06-2020. The company’s EBITDA came in at -$27.43 million which compares well with its peers.

VIR Return on Equity (ROE) is -81.10%, and its Return on Assets is -42.30%. All told, it is clear that, VIR needs to be on your watchlist.

Find out when VIR reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. VIR has a short ratio of 2.87 and outstanding shares of 114.98M.

Company Outlook

VIR has seen increased volume after this news and investors are putting their support behind the value proposition. Traders will also note the company’s earnings per share came in at -6.17. Vir Biotechnology Inc. VIR also noted assets of $672.24 million at the end of the last quarter. Investors should also keep an eye on sector updates as VIR has historically followed its peers on positive news.

All told, Vir Biotechnology Inc. VIR has strung together solid data and demonstrated underlying fundamentals. At its current valuation, VIR represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Vir Biotechnology Inc. VIR is now commanding a market cap of 6.41B and a float of 109.09M. VIR is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of VIR stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in VIR, either long or short, and we have not been compensated for this article.

Latest article

Synchrony Financial (NYSE:SYF) is Waving the Bear Flag

Synchrony Financial (SYF) shares are trading at lower $29.45 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

The Forecast Just Changed on Ovintiv Inc. (NYSE:OVV)

Ovintiv Inc. (OVV) shares are trading at lower $12.20 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Range Resources Corporation (NYSE:RRC) on the Path to Ruin

Range Resources Corporation (RRC) shares are trading at lower $7.16 and the avg recommendation for the stock is Hold, while the current analyst price...

The Last Few Sessions Have Exelon Corporation (EXC) Soaring

Exelon Corporation (EXC) shares are trading at lower $41.87 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Bloom Energy Corporation (NYSE:BE) Stock is Plummeting, Here is Why

Bloom Energy Corporation (BE) shares are trading at lower $18.67 and the avg recommendation for the stock is Moderate Buy, while the current analyst...